Polyplastics-Evonik Corporation announces use of TROGAMID® in exclusive Seiko Optical Products eyewear
Polyplastics-Evonik Corporation, a joint venture between Evonik Industries AG and Daicel Corporation, has announced that its high-performance transparent polyamide, TROGAMID®, has been adopted in the new “Seiko Light and Fitting – Black Leaf” eyewear series by Seiko Optical Products Co., Ltd.
- TROGAMID® high-performance transparent polyamide now featured in Seiko Light and Fitting – Black Leaf eyewearFeatures 88% optical transparency
- Use of TROGAMID® allows for eyewear’s thin, lightweight, durable designs
- Eyewear frames feature TROGAMID® logo in gold, as sign of high reliability and value
Tokyo. Polyplastics-Evonik Corporation, a joint venture between Evonik Industries AG and Daicel Corporation, has announced that its high-performance transparent polyamide, TROGAMID®, has been adopted in the new “Seiko Light and Fitting – Black Leaf” eyewear series by Seiko Optical Products Co., Ltd.
Developed to meet the seemingly contradictory demands of a luxurious yet comfortable design, Seiko Optical Products’ innovative eyewear frame was envisioned to achieve a “thin, lightweight, and luxurious design” that is difficult to realize with conventional acetate materials. As such, the team sought new material possibilities from the early stages of development. They then turned their attention to TROGAMID®.
“When frames are heavy, they put pressure on the ears and nose during long wear. On the other hand, if they’re too light, they can lose their sense of luxury. TROGAMID® enabled us to achieve both,” said a developer from the Frame Division at Seiko Optical Products.
TROGAMID® was highly evaluated as an ideal material for eyewear frames. Its high toughness allows for thin, lightweight, and durable designs, providing a comfortable wearing experience. The frames feature a luxurious design with the “TROGAMID®” logo engraved in gold, directly conveying the material’s reliability and brand value to users.
Polyplastics-Evonik Corporation will continue to support product development across various industries, including eyewear, through the provision of high-performance resins.
For more information on Evonik’s TROGAMID® portfolio, please visit: https://www.trogamid.com/en
For more information on the Polyplastics-Evonik Corporation joint venture, please visit: http://pp-evonik.com/english/company/
About Polyplastics-Evonik Corporation Ltd.
This company was established in 1970 as a joint venture between Huels AG (now Evonik Industries AG) and Daicel Chemical Industries, Ltd. (now Daicel Corporation). It has created such high-quality, high-performance polymers as nylon 12 and transparent nylon. In recent years, the company has broadened its product lineup to encompass C8 & C12 alicyclic compounds, polymethyl methacrylate, and super-engineering thermoplastics, and polyether ether ketone. The company leverages new perspectives and ideas in an ongoing drive to improve product quality and reinforce technical services. In December 2021, Daicel Corporation transferred its stake in this company to wholly owned subsidiary Polyplastics Co., Ltd. The company was renamed Polyplastics-Evonik Corporation on April 1, 2022.
About Evonik Industries AG
Evonik goes beyond the boundaries of chemistry with its combination of innovative strength and leading technological expertise. The global chemical company, headquartered in Essen, Germany, is active in more than 100 countries and generated sales of €15.2 billion and earnings (adjusted EBITDA) of €2.1 billion in 2024. The common motivation of the approximately 32,000 employees: to provide customers with a decisive competitive advantage with tailor-made products and solutions as a superforce for industry, thereby improving people's lives. In all markets. Every day.
About Evonik’s Advanced Technologies Segment
The Smart Materials division includes businesses with innovative materials that enable resource-The Advanced Technologies segment includes Evonik’s market-leading businesses that leverage technological expertise and process know-how. These businesses feature high-performance polymers and crosslinking agents, hydrogen peroxide and silica, as well as feed ingredients. In 2024, the segment generated sales of €6.1 billion with around 8,000 employees.
Disclaimer
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.